7 terminated. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Terminated 7 |
Follow Head and Neck Neoplasms: new trials by email Literature Review of Head and Neck Neoplasms trials Research Report on Head and Neck Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery Remimazolam Besylate, Propofol, Midazolam - Sedation, ICU | Phase 4 | Terminated | Nanfang Hospital, Southern Medical University | 117 | 2022-03-16 | 2026-07-02 |
| Nutrition and Pharmacological Algorithm for Oncology Patients Study Dexamethasone, Dronabinol, Mirtazapine - Oncologic Complications, Quality of Life | Phase 4 | Terminated | Montefiore Medical Center | 1 | 2021-03-01 | 2022-11-16 |
| Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy Levothyroxine - Thyroid Cancer, Postsurgical Hypothyroidism | Phase 4 | Terminated | University of Texas Southwestern Medical Center | 14 | 2017-02-01 | 2020-12-01 |
| 99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients 99mTc sestamibi - Thyroid Cancer | Phase 4 | Terminated | Medstar Health Research Institute | 4 | 2016-10-01 | 2022-07-26 |
| A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC Sodium Glycididazole - Esophageal Neoplasms | Phase 4 | Terminated | Shandong Cancer Hospital and Institute | 2 | 2016-08-01 | 2019-10-11 |
| A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC Sodium Glycididazole - Esophageal Neoplasms | Phase 4 | Terminated | Shandong Cancer Hospital and Institute | 8 | 2016-07-05 | 2019-10-11 |
| Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Cetuximab, Mitomycin-C/ 5-Fluorouracil - Head and Neck Neoplasms | Phase 4 | Terminated | Medical University Innsbruck | 4 | 2014-04-01 | 2020-05-18 |
Esophageal Neoplasms (2) · Thyroid Neoplasms (2) · Lung Neoplasms (1) · Malnutrition (1) · Mouth Neoplasms (1) · Pancreatic Neoplasms (1) · Thyroid Diseases (1)
Neoplasms (7) · Neoplasms by Site (7) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Esophageal Diseases (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Lung Diseases (1) · Mouth Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Pancreatic Diseases (1)
sodium glycididazole (2) · Cetuximab (1) · Dexamethasone (1) · Diet Therapy (1) · Dronabinol (1) · Fluorouracil (1) · Midazolam (1) · Mirtazapine (1) · Mitomycin (1) · Propofol (1) · Technetium Tc 99m Sestamibi (1) · Thyroxine (1)
Shandong Cancer Hospital and Institute (2) · Medical University Innsbruck (1) · Medstar Health Research Institute (1) · Montefiore Medical Center (1) · Nanfang Hospital, Southern Medical University (1) · University of Texas Southwestern Medical Center (1)
China (3) · United States (3) · Austria (1)
Jinming Yu, Ph.D, M.D (2) · Alex Tessnow, MD (1) · Douglas Van Nostrand, MD (1) · Justin Tang, MD (1)
2019 (1)